$3.11
+0.20 (+6.69%)
Open$2.91
Previous Close$2.92
Day High$3.11
Day Low$2.91
52W High$8.63
52W Low$2.80
Volume—
Avg Volume7.9K
Market Cap37.81M
P/E Ratio—
EPS$-0.68
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+1,009.6% upside
Current
$3.11
$3.11
Target
$34.51
$34.51
$26.32
$34.51 avg
$56.88
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 2.23M | 2.24M | 21.69M |
| Net Income | -8,999,397 | -8,155,731 | 2.61M |
| Profit Margin | -404.1% | -383.9% | 12.0% |
| EBITDA | -8,883,563 | -8,498,021 | 4.63M |
| Free Cash Flow | — | — | 2.95M |
| Rev Growth | -0.7% | -0.7% | +19.5% |
| Debt/Equity | 0.02 | 0.02 | 0.66 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |